Apoptosis in glioma-bearing rats after neural stem cell transplantation.

Hua Li, Zhenjun Chen, Shaopeng Zhou
Author Information
  1. Hua Li: Department of Neurology, the 476 Hospital of Chinese PLA, Fuzhou 350002, Fujian Province, China.
  2. Zhenjun Chen: Department of Neurology, the 476 Hospital of Chinese PLA, Fuzhou 350002, Fujian Province, China.
  3. Shaopeng Zhou: Department of Anesthesiology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong Province, China.

Abstract

Abnormal activation of the Ras/Raf/Mek/Erk signaling cascade plays an important role in glioma. Inhibition of this aberrant activity could effectively hinder glioma cell proliferation and promote cell apoptosis. To investigate the mechanism of glioblastoma treatment by neural stem cell transplantation with respect to the Ras/Raf/Mek/Erk pathway, C6 glioma cells were prepared in suspension and then infused into the rat brain to establish a glioblastoma model. Neural stem cells isolated from fetal rats were then injected into the brain of this glioblastoma model. Results showed that Raf-1, Erk and Bcl-2 protein expression significantly increased, while Caspase-3 protein expression decreased. After transplantation of neural stem cells, Raf-1, Erk and Bcl-2 protein expression significantly decreased, while Caspase-3 protein expression significantly increased. Our findings indicate that transplantation of neural stem cells may promote apoptosis of glioma cells by inhibiting Ras/Raf/Mek/Erk signaling, and thus may represent a novel treatment approach for glioblastoma.

Keywords

References

  1. IUBMB Life. 2012 Sep;64(9):783-94 [PMID: 22837216]
  2. Methods Mol Biol. 2010;661:3-38 [PMID: 20811974]
  3. J Cell Sci. 2005 Aug 15;118(Pt 16):3569-72 [PMID: 16105880]
  4. Stem Cells. 2007 Apr;25(4):871-4 [PMID: 17185607]
  5. Neoplasia. 2008 May;10(5):501-10 [PMID: 18472967]
  6. Zhonghua Yi Xue Za Zhi. 2007 Jan 16;87(3):150-4 [PMID: 17425843]
  7. J Surg Oncol. 2004 Apr 1;86(1):34-40 [PMID: 15048678]
  8. Anticancer Drugs. 2012 Jan;23(1):81-9 [PMID: 21934602]
  9. Biochim Biophys Acta. 2010 Oct;1802(10):872-80 [PMID: 20056145]
  10. Nat Rev Cancer. 2003 Jan;3(1):11-22 [PMID: 12509763]
  11. Am J Physiol Gastrointest Liver Physiol. 2011 Oct;301(4):G719-30 [PMID: 21737780]
  12. Brain Tumor Pathol. 2012 Apr;29(2):73-86 [PMID: 22218709]
  13. J Mol Histol. 2008 Dec;39(6):561-9 [PMID: 18814044]
  14. J Neurooncol. 2011 Jul;103(3):491-501 [PMID: 20872043]
  15. Pancreas. 2003 Jan;26(1):65-70 [PMID: 12499919]
  16. Stem Cells. 2008 Jun;26(6):1575-86 [PMID: 18339768]
  17. J Neurosci. 2006 Jun 21;26(25):6781-90 [PMID: 16793885]
  18. Chin Med J (Engl). 2011 Sep;124(17):2578-83 [PMID: 22040406]
  19. Cell. 2012 Mar 30;149(1):36-47 [PMID: 22464322]
  20. Cancer Cell. 2010 Jan 19;17(1):98-110 [PMID: 20129251]
  21. Oncogene. 2010 Jan 21;29(3):335-44 [PMID: 19855433]
  22. Histol Histopathol. 1999 Jan;14(1):37-44 [PMID: 9987648]
  23. Biochim Biophys Acta. 2007 Aug;1773(8):1299-310 [PMID: 17188374]
  24. J Clin Endocrinol Metab. 2007 Mar;92(3):1041-8 [PMID: 17192291]
  25. Biorheology. 2009;46(6):529-38 [PMID: 20164634]
  26. Mol Cell. 2010 Feb 12;37(3):299-310 [PMID: 20159550]
  27. Stem Cells. 2008 Jan;26(1):254-65 [PMID: 17962704]
  28. Stem Cells. 2012 May;30(5):1021-9 [PMID: 22311724]
  29. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD007104 [PMID: 18425979]
  30. Cell Death Differ. 1999 Feb;6(2):99-104 [PMID: 10200555]
  31. Neurol Res. 2007 Dec;29(8):847-54 [PMID: 17609021]
  32. Science. 2006 Feb 10;311(5762):847-51 [PMID: 16469926]
  33. Immune Netw. 2009 Jun;9(3):90-7 [PMID: 20107538]
  34. Cancers (Basel). 2011 Aug 10;3(3):3242-78 [PMID: 24212955]
  35. Exp Neurol. 2003 Jun;181(2):115-29 [PMID: 12781986]
  36. Neuro Oncol. 2006 Apr;8(2):119-26 [PMID: 16524944]
  37. Genes Cells. 2006 Sep;11(9):1097-113 [PMID: 16923128]
  38. J Intensive Care Med. 2009 Jan-Feb;24(1):47-53 [PMID: 19033321]
  39. Angiogenesis. 2009;12(1):91-100 [PMID: 19225898]
  40. J Neurosci Res. 2008 Jun;86(8):1670-9 [PMID: 18241062]
  41. Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11839-44 [PMID: 15280535]
  42. J Neurosci. 2001 Oct 15;21(20):8108-18 [PMID: 11588183]
  43. J Cancer Res Clin Oncol. 2009 Dec;135(12):1777-82 [PMID: 19582475]
  44. Eur J Biochem. 1998 Feb 15;252(1):1-15 [PMID: 9523706]
  45. J Cancer Res Clin Oncol. 2009 Feb;135(2):235-40 [PMID: 18636275]
  46. Leuk Lymphoma. 2004 Sep;45(9):1905-11 [PMID: 15223653]
  47. Oncologist. 2009 Jun;14(6):621-36 [PMID: 19487335]
  48. Genes Cancer. 2011 Mar;2(3):344-58 [PMID: 21779504]
  49. Exp Biol Med (Maywood). 2012 Aug;237(8):933-42 [PMID: 22875343]
  50. Acta Neuropathol. 2007 Aug;114(2):121-33 [PMID: 17588166]
  51. Neurochem Res. 2007 Dec;32(12):2194-202 [PMID: 17616812]
  52. Curr Microbiol. 2011 Oct;63(4):341-6 [PMID: 21779937]
  53. Stem Cell Rev. 2008 Sep;4(3):203-10 [PMID: 18595010]
  54. Brain Pathol. 2006 Apr;16(2):143-54 [PMID: 16768755]
  55. Oncogene. 2011 Mar 17;30(11):1341-50 [PMID: 21057530]
  56. Acta Neurochir (Wien). 2009 Dec;151(12):1655-61 [PMID: 19597759]
  57. Curr Opin Oncol. 2009 Nov;21(6):516-23 [PMID: 19730103]
  58. J Neurol Neurosurg Psychiatry. 2004 Jun;75 Suppl 2:ii2-11 [PMID: 15146033]
  59. Mol Pharm. 2011 Oct 3;8(5):1559-72 [PMID: 21718006]
  60. Urology. 2009 Jan;73(1):193-9 [PMID: 18692875]